(0.17%) 5 140.00 points
(0.18%) 38 511 points
(0.22%) 17 886 points
(-0.72%) $83.25
(1.92%) $1.960
(0.01%) $2 347.40
(0.23%) $27.60
(0.79%) $929.35
(-0.16%) $0.933
(-0.23%) $11.00
(-0.26%) $0.798
(1.05%) $92.84
0.05% INR 1 634.00
Live Chart Being Loaded With Signals
Poly Medicure Limited manufactures and sells medical devices. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I...
Stats | |
---|---|
Tagesvolumen | 27 374.00 |
Durchschnittsvolumen | 88 459.00 |
Marktkapitalisierung | 156.82B |
EPS | INR0 ( 2024-02-02 ) |
Nächstes Ertragsdatum | ( INR0 ) 2024-05-06 |
Last Dividend | INR3.00 ( 2023-09-21 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 62.92 |
ATR14 | INR1.048 (0.06%) |
Volumen Korrelation
Poly Medicure Limited Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Poly Medicure Limited Korrelation - Währung/Rohstoff
Poly Medicure Limited Finanzdaten
Annual | 2022 |
Umsatz: | INR11.15B |
Bruttogewinn: | INR7.09B (63.61 %) |
EPS: | INR18.69 |
FY | 2022 |
Umsatz: | INR11.15B |
Bruttogewinn: | INR7.09B (63.61 %) |
EPS: | INR18.69 |
FY | 2022 |
Umsatz: | INR9.17B |
Bruttogewinn: | INR4.84B (52.75 %) |
EPS: | INR15.28 |
FY | 2021 |
Umsatz: | INR7.75B |
Bruttogewinn: | INR4.39B (56.59 %) |
EPS: | INR15.25 |
Financial Reports:
No articles found.
Poly Medicure Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR2.50 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR3.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.375 | 2012-09-13 |
Last Dividend | INR3.00 | 2023-09-21 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 15 | -- |
Total Paid Out | INR20.13 | -- |
Avg. Dividend % Per Year | 0.27% | -- |
Score | 2.15 | -- |
Div. Sustainability Score | 4.15 | |
Div.Growth Potential Score | 5.12 | |
Div. Directional Score | 4.63 | -- |
Year | Amount | Yield |
---|---|---|
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR2.00 | 0.80% |
2019 | INR2.00 | 0.90% |
2020 | INR2.00 | 0.92% |
2021 | INR2.50 | 0.49% |
2022 | INR2.50 | 0.26% |
2023 | INR3.00 | 0.33% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RPPL.NS | Dividend Junior | 2023-08-24 | Annually | 6 | 0.31% | |
LIKHITHA.NS | Dividend Junior | 2023-09-20 | Annually | 4 | 0.46% | |
GANESHHOUC.NS | Dividend Junior | 2023-08-31 | Sporadic | 18 | 0.18% | |
APTUS.NS | Dividend Junior | 2023-05-12 | Semi-Annually | 3 | 0.32% | |
TECHNOE.NS | Dividend Junior | 2023-09-15 | Annually | 16 | 1.13% | |
ONGC.NS | Dividend Knight | 2023-08-18 | Semi-Annually | 28 | 4.00% | |
IOC.NS | Dividend Knight | 2023-07-28 | Semi-Annually | 28 | 5.08% | |
CRAFTSMAN.NS | Dividend Knight | 2023-06-19 | Annually | 3 | 0.13% | |
SHANTIGEAR.NS | Dividend Junior | 2023-07-11 | Annually | 23 | 1.02% | |
MANGCHEFER.NS | Dividend Junior | 2023-09-18 | Annually | 17 | 1.18% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.191 | 1.500 | 6.19 | 9.28 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.193 | 1.500 | 8.97 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 30.75 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 10.15 | 2.00 | 6.62 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 10.15 | 2.00 | 4.93 | 9.85 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.650 | 1.000 | 2.50 | 2.50 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.248 | 1.000 | 7.04 | 7.04 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 4.15 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 63.65 | 1.000 | 3.67 | 0 | [1 - 100] |
returnOnEquityTTM | 0.193 | 2.50 | 9.34 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 10.15 | 2.00 | 6.62 | 9.85 | [0 - 30] |
dividendYielPercentageTTM | 0.182 | 1.500 | 5.45 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 10.15 | 2.00 | 6.62 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 323.55 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0746 | 1.000 | -0.634 | 0 | [0.1 - 0.5] |
Total Score | 5.12 |
Poly Medicure Limited
Poly Medicure Limited manufactures and sells medical devices. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal tubes, tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. In addition, it offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. Further, it provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, erythrocyte sedimentation rate pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, and universal caps. The company was incorporated in 1995 and is based in New Delhi, India.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.